Drug price history · CMS NADAC read 11 November 2026

What have pharmacies paid for Cefazolin since 2013?

What pharmacies pay, not what you pay. Cefazolin has 1 product in the CMS NADAC survey, 1 product with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged. Cefazolin 1 GM Vial: $0.740 per unit at the 2013 survey and $1.07 at 2026 (+45%).
Not medical or financial advice. This page reports what pharmacies pay to acquire a drug, from the CMS NADAC survey. It is not what you will be charged, and it says nothing about which medicine is right for you. Ask your pharmacist or prescriber.
Cefazolin1 product in NADAC
1product with a price history
  1. Cefazolin has 1 product in the CMS NADAC survey, 1 product with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged.
  2. Between each product's first and latest year-end survey, no product costs pharmacies less and 1 product costs more, by more than 5 percent, per unit as CMS states it.
  3. This is a per-unit acquisition cost, not a retail price, a copay or an insurer's price, and it says nothing about why a price moved.

Cefazolin 1 GM Vial

Generic

$0.740 per unit at the 2013 year-end survey (8 NDCs) and $1.07 at the 2026 survey (10 NDCs): +45%.

$0$1.352013: median $0.740 per unit, 8 NDCs priced2014: median $1.35 per unit, 8 NDCs priced2015: median $0.646 per unit, 8 NDCs priced2024: median $0.998 per unit, 11 NDCs priced2025: median $0.974 per unit, 10 NDCs priced2026: median $1.07 per unit, 10 NDCs priced201320142015202420252026
year-end median across the NDCs pricedlowest to highest NDC
Year-end surveyMedian per unitLowest to highestNDCs priced
2013 (2013-12-25)$0.7408
2014 (2014-12-31)$1.358
2015 (2015-12-30)$0.6468
2024 (2024-12-25)$0.99811
2025 (2025-12-31)$0.97410
2026 (2026-11-11)$1.0710

CMS National Average Drug Acquisition Cost, year-end surveys 2013 to 2026. A pharmacy acquisition cost, not a retail price. About NADAC.

How many companies make Cefazolin?

The FDA Orange Book lists 5 generic makers as marketed in its largest dosage form for Cefazolin, and the first generic approval is dated 10 September 1985. The acquisition costs above are what pharmacies pay across the NDCs priced; the Orange Book count is a separate record and this page does not say that more makers lowered a price. See each maker and the patents still listed on OmniRx.

Where can you go from this record?

Open it in the check to search another drug, or see the CMS pharmacy pricing page for what NADAC measures. For who makes the generic and which patents are listed, see the generic competition check for Cefazolin on OmniRx. To check whether a drug is in shortage, see the FDA drug shortages page.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the CMS pharmacy pricing page, year-end surveys 2013 to 2026 (latest 11 November 2026).